Clinical trial Recruiting at 1 site Observational Ages 18 and up

See if Continuous Glucose Monitoring can help diagnose dumping syndrome after esophagectomy

Official title: Prospective Observational Study on the Utility of Continuous Glucose Monitoring for the Diagnosis of Dumping Syndrome After Esophagectomy

Run by Samsung Medical Center · NCT07605481 · Data updated 2026-11-12

Researchers are testing whether a wearable continuous glucose monitor can help spot dumping syndrome in people who had esophageal cancer surgery with a stomach tube reconstruction.

More Esophagectomy trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment30 (estimated)
SponsorSamsung Medical Center
Academic / other
Locations1 site (Seoul, Gangnam-gu Irwon-Ro 81)
StatusRecruiting
StartedJune 15, 2026
Main results expectedDecember 31, 2028
Study endsDecember 31, 2028
Registry record updatedMay 26, 2026
Trial IDNCT07605481 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) who had esophagectomy with gastric tube reconstruction for esophageal cancer and have a Sigstad score of 7 or higher.

Probably not a fit

Patients with diabetes and autonomic neuropathy or those unable to complete the diagnostic procedure may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study will assess the usefulness of continuous glucose monitoring (CGM) to diagnose dumping syndrome in adults who have undergone esophagectomy with gastric tube reconstruction. Participants will be adults 18 years or older with a Sigstad score of 7 or higher who had surgery for esophageal cancer. CGM data will be analyzed to identify glucose patterns associated with dumping symptoms and late dumping. The study aims to determine if CGM can provide a practical tool for early detection in this patient group. No interventional treatment is described in the protocol.

Why it matters

Potential benefit: If successful, CGM could enable earlier and easier detection of dumping syndrome, potentially leading to timely management.

How similar studies have gone: Prior research has explored CGM for postprandial glucose monitoring, but its specific use for diagnosing dumping syndrome after esophagectomy is novel and not yet established as standard practice.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

-1. aged 18 or older. 2. people who underwent esophagectomy and gastric tube reconstruction for esophageal cancer.

3\. Sigstad score of 7 or higher.

Exclusion Criteria:

* 1\. Diabetes with autonomic neuropathy. 2. Inability to complete the diagnostic procedure (e.g., cognitive decline). 3. Refusal to participate.

Where it's running

  • Samsung Medical Center
    Seoul, Gangnam-gu Irwon-Ro 81, South Korea
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.